Attached files
| file | filename |
|---|---|
| 10-Q/A - ADVANCED MEDICAL ISOTOPE CORP. 09/30/09 10-Q/A FIRST AMENDMENT - VIVOS INC | advancedmedical_10qa-093009.htm |
| EX-31.1 - CEO CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES - OXLEY ACT OF 2002 - VIVOS INC | exhibit_31-1.htm |
| EX-31.2 - CFO CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES - OXLEY ACT OF 2002 - VIVOS INC | exhibit_31-2.htm |
EXHIBIT 32
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Advanced Medical Isotope Corporation (the "Company") on Form 10-Q /A for the quarter ended September 30, 2009 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), The undersigned, James
C. Katzaroff, Chief Executive Officer and I, L. Bruce Jolliff, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
|
January 27, 2010 |
|||||
|
ADVANCED MEDICAL ISOTOPE CORPORATION |
|||||
|
By: |
/s/ James C. Katzaroff |
||||
|
Name: James C. Katzaroff |
|||||
|
Title: Chief Executive Officer and Chairman |
|||||
|
By: |
/s/ L. Bruce Jolliff |
||||
|
Name: L. Bruce Jolliff |
|||||
|
Title: Chief Financial Officer |